Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Genomtec SA logo — Molecular diagnosis everywhere, at the right time and for th...

Genomtec SA

Molecular diagnosis everywhere, at the right time and for the right price.

Founded 2016 Poland Poland 26 employees Grant Total: $26.50M Biotechnology, Health Care +2

General Information

Company Name Genomtec SA
Founded Year 2016
Location Poland Poland
Employees 26
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Genomtec SA. To contact Genomtec SA, visit genomtec.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Genomtec SA compare?

A PDF of Genomtec SA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Genomtec SA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Genomtec SA

Genomtec is a MedTech company founded in 2016 with the slogan "Molecular diagnosis everywhere, at the right time and for the right price." The company specializes in advanced technologies for genetic diagnostics. Their flagship project, the Genomtec ID mobile diagnostic system, holds EU CE-IVD certification for the Genomtec ID RP5-PLEX diagnostic panel, enabling fast and precise molecular analysis for common respiratory tract infections. The technology, protected by 11 patents and over 35 pending applications across global markets, utilizes microfluidic and proprietary patented SNAAT® isothermal technology. With a focus on biotechnology and healthcare, Genomtec is headquartered in Wroclaw, Poland and has a branch in the UK. Their second project, "OncoSNAAT," aims to develop automated mutation detection technology for clinical oncology utilizing lab-on-chip solutions. The company has recently received a PLN21.60M grant investment on 29th December 2023 from the Polish Agency for Enterprise Development. Genomtec's team comprises experienced individuals from various fields, combining confidence in molecular diagnostics with simplicity and cost reduction. With a passion for creation, the company works with young, ambitious scientists and constructors, alongside seasoned experts in commercialization and effective market strategies.

Business keywords: Molecular Diagnostics, Genetic Analyzer, Mobile Technology, Infection Detection, Antibiotic Resistance, Cancer Cases, Biological Material Testing, R&D, Medtech, Diagnostic Technology, Healthcare Innovation, Genomic Analysis, Medical Device, Biomedical Engineering

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant PLN21.60M 1
Polish Agency for Enterprise Development
Polish Agency for Enterprise Development
29 Dec 2023
Funding Round €2.90M -
28 Apr 2023
Seed Round $2.00M 1
KnowledgeHub Fund
KnowledgeHub Fund
09 Oct 2020

Genomtec SA Alternatives & Competitors

View All Alternatives
Genomtec SA vs
Applied BioCode, Inc.
Applied BioCode, Inc. United States

The Ideal Choice for Cost-Effective High Throughput Syndromic Panels

Venture round
60 employees
Biotechnology, Health Care
Compare Genomtec SA vs Applied BioCode, Inc.
Genomtec SA vs
Astek Diagnostics
Astek Diagnostics United States

One-hour antibiotic sensitivity testing

Non Equity Assistance
14 employees
Health Care, Medical Devices
Compare Genomtec SA vs Astek Diagnostics
Genomtec SA vs
EMPE Diagnostics
EMPE Diagnostics Sweden

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited...

Series A
27 employees
Biotechnology, Health Care
Also compare with: Genomtec SA vs SDS Optic Inc. SDS Optic Inc. View all alternatives

FAQ About Genomtec SA

Molecular diagnosis everywhere, at the right time and for the right price.
Genomtec SA was founded in 2016.
Genomtec SA is headquartered in Poland.
Genomtec SA operates in Biotechnology, Health Care, Life Sciences and Medical Devices. Its work centres on Molecular Diagnostics, Genetic Analyzer, Mobile Technology and Infection Detection.
Genomtec SA has approximately 26 employees.
Genomtec SA has completed 3 funding rounds, raising a total of $26.50M. The latest funding stage is Grant.
Top alternatives and competitors to Genomtec SA include Applied BioCode, Inc., Astek Diagnostics, EMPE Diagnostics, SDS Optic Inc., Mainz Biomed. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genomtec SA and Applied BioCode, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Genomtec SA, https://bouncewatch.com/company/genomtec, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout